XML 79 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Additional Paid- in Capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2017 $ 10,616 $ 161,067,538 $ (157,420,027) $ 3,658,127
Beginning Balance, Shares at Dec. 31, 2017 10,615,724      
Issuance of common stock for research and development intellectual property $ 13,914 116,030,972   116,044,886
Issuance of common stock for research and development intellectual property, Shares 13,914,255      
Issuance of common stock and warrants in private placement $ 18,800 73,101,200   73,120,000
Issuance of common stock and warrants in private placement, Shares 18,800,000      
Fees and legal costs relating to private placement   (6,175,000)   (6,175,000)
Stock options exercised for cash $ 10 18,115   18,125
Stock options exercised for cash, Shares 10,416      
Stock options exercised for cash $ 1,499 4,352,129   4,353,628
Stock options exercised for cash, shares 1,499,324      
Stock warrants cashless exercised $ 280 (280)    
Stock warrants cashless exercised, Shares 280,760      
Stock-based compensation $ 329 16,350,263   16,350,592
Stock-based compensation (in shares) 327,786      
Repurchase of common stock to pay for employee withholding taxes $ (8) (71,702)   (71,710)
Repurchase of common stock to pay for employee withholding taxes, Shares (7,561)      
Fair value of repriced warrants as inducement   727,513 (727,513)  
Net loss     (147,957,910) (147,957,910)
Ending Balance at Dec. 31, 2018 $ 45,440 365,400,748 (306,105,450) 59,340,738
Ending Balance, Shares at Dec. 31, 2018 45,440,704      
Stock options exercised for cash $ 12 57,732   57,744
Stock options exercised for cash, Shares 11,980      
Stock options exercised for cash $ 190 758,543   758,733
Stock options exercised for cash, shares 190,258      
Stock warrants cashless exercised $ 9 (9)    
Stock warrants cashless exercised, Shares 9,449      
Stock-based compensation $ 77 5,356,895   5,356,972
Stock-based compensation (in shares) 76,440      
Fair value of repriced warrants as inducement       728,000
Net loss     (21,427,964) (21,427,964)
Ending Balance at Dec. 31, 2019 $ 45,728 $ 371,573,909 $ (327,533,414) $ 44,086,223
Ending Balance, Shares at Dec. 31, 2019 45,728,831